Table 4.
Variables | Before Supplementation | p Value | After Supplementation | p Value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre-Exercise x ± SD |
Post-Exercise x ± SD |
Recovery x ± SD |
Pre CON vs. SUPL |
Post CON vs. SUPL |
Recovery CON vs. SUPL |
Pre-Exercise x ± SD |
Post-Exercise x ± SD |
Recovery x ± SD |
Pre CON vs. SUPL |
Post CON vs. SUPL |
Recovery CON vs. SUPL |
|
RBC (109 × mL−1) |
||||||||||||
PLACEBO | 4.36 ± 0.37 | 4.52 ± 0.37 | 4.19 ± 0.34 c | 0.929 | 0.936 | 0.094 | 4.63 ± 0.45 | 4.88 ± 0.45 | 4.31 ± 0.27 c | 0.998 | 0.019 | 0.873 |
COLOSTRUM | 4.22 ± 0.25 | 4.35 ± 0.27 | 3.83 ± 0.37 b | 4.50 ± 0.45 | 4.35 ± 0.27 | 4.42 ± 0.21 | ||||||
Hb (g × L−1) |
||||||||||||
PLACEBO | 13.51 ± 1.20 | 13.89 ± 1.13 a | 12.62 ± 1.16 b | 0.962 | 0.994 | 0.540 | 13.93 ± 1.07 | 14.80 ± 1.75 | 12.95 ± 0.78 b | 0.845 | 0.579 | 0.999 |
COLOSTRUM | 13.21 ± 0.78 | 13.54 ± 0.75 a | 11.95 ± 0.91 b | 13.27 ± 0.44 | 13.99 ± 0.73 | 12.80 ± 1.01 b | ||||||
HTC (%) |
||||||||||||
PLACEBO | 37.84 ± 3.05 | 39.13 ± 2.93 a | 35.82 ± 2.83 b | 0.823 | 0.788 | 0.023 | 40.95 ± 3.27 | 43.73 ± 4.86 | 37.94 ± 2.30 b | 0.772 | 0.376 | 0.999 |
COLOSTRUM | 36.74 ± 2.01 | 37.6 ± 1.87 a | 32.76 ± 2.57 b | 38.89 ± 1.35 | 41.01 ± 1.87 a | 37.70 ± 2.67 b | ||||||
Mioglobin (µg × L−1) |
||||||||||||
PLACEBO | 17.11 ± 5.03 | 19.06 ± 3.04 a | 29.69 ± 3.85 b | 0.309 | 0.203 | 0.994 | 25.69 ± 8.31 | 27.27 ± 6.60 | 29.60 ± 7.25 | 0.964 | 0.671 | 0.716 |
COLOSTRUM | 19.27 ± 3.50 | 21.21 ± 2.13 a | 29.41 ± 2.92 b | 26.51 ± 10.87 | 28.25 ± 8.43 | 29.82 ± 7.47 |
Note. Values are presented as mean ± SD; Significant differences p < 0,05; a Pre-exercise vs. Post-exercise; b Pre-exercise vs. Recovery; c Post-exercise vs. Recovery. RBC red blood cells; Hb hemoglobin; HTC hematocrit; TIBC, total iron-binding capacity; UIBC, unsaturated iron-binding capacity. Bold values denote statistical significance at the p < 0.05 level.